Hematopoietic cell transplantation in 2020: summary of year 2 recommendations of the National Marrow Donor Program's System Capacity Initiative.
The National Marrow Donor Program, in partnership with the American Society for Blood and Marrow Transplantation, sponsored and organized a series of symposia to identify complex issues affecting the delivery of hematopoietic cell transplantation (HCT) and to collaboratively develop options for solutions. "Hematopoietic Cell Transplantation in 2020: A System Capacity Initiative" used a deliberative process model to engage professional organizations, experts, transplant centers, and stakeholders in a national collaborative effort. Year 2 efforts emphasized data analysis and identification of innovative ideas to increase HCT system efficiency, address future capacity requirements, and ensure adequate reimbursement for HCT programs to meet the projected need for HCT. This report highlights the deliberations and recommendations of Year 2 and the associated symposium held in September 2011.
Health Services Research, National Marrow Donor Program, Minneapolis, Minnesota 55413, USA. edenzen@nmdp.org
Ellen M
EM
Denzen
Navneet S
NS
Majhail
Stacy
S
Stickney Ferguson
Claudio
C
Anasetti
Arthur
A
Bracey
Linda
L
Burns
Richard
R
Champlin
Jeffrey
J
Chell
Helen
H
Leather
Michael
M
Lill
Richard T
RT
Maziarz
Erin
E
Medoff
Joyce
J
Neumann
Kim
K
Schmit-Pokorny
Edward L
EL
Snyder
Laura
L
Wiggins
Deborah S
DS
Yolin Raley
Elizabeth A
EA
Murphy
D003226:Congresses as Topic; D003695:Delivery of Health Care / Q000191:economics / Q000379:methods / Q000458:organization & administration; D005260:Female; D019983:Guideline Adherence / Q000191:economics / Q000458:organization & administration / Q000592:standards; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D012955:Societies, Medical; D014019:Tissue Donors